Salajegheh
Mastooreh Salajegheh, Amherst, MA US
Patent application number | Description | Published |
---|---|---|
20130145199 | METHODS AND SYSTEMS FOR IMPROVING SECURITY IN ZERO-POWER DEVICES - Methods and systems for providing lime information in intermittently powered devices that are batteryless and operate purely on harvested energy (also referred to as zero power devices). The method of these teachings for improving security of zero power devices includes determining an estimate of time using a decay of data in a volatile device, and deciding whether to respond to a query based on the estimate of time. | 06-06-2013 |
Mastooreh Salajegheh, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20140317734 | Adaptive Observation of Behavioral Features on a Mobile Device - Methods, devices and systems for detecting suspicious or performance-degrading mobile device behaviors intelligently, dynamically, and/or adaptively determine computing device behaviors that are to be observed, the number of behaviors that are to be observed, and the level of detail or granularity at which the mobile device behaviors are to be observed. The various aspects efficiently identify suspicious or performance-degrading mobile device behaviors without requiring an excessive amount of processing, memory, or energy resources. | 10-23-2014 |
Mohammad K. Salajegheh, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20140370526 | DETECTING INCLUSION BODY MYOSITIS - Methods, devices, kits and systems for diagnosing inclusion body myositis (IBM) are provided. Methods, devices, kits and systems involves detecting the presence and/or level of autoantibodies that are reactive against at least a ˜43 kilodalton (kDa) protein or ˜43 kDa protein band from a muscle lysate or a mammalian cell lysate, or autoantibodies that are reactive against a cytosolic 5′-nucleotidase 1A protein (NT5C1A), or a cytosolic 5′-nucleotidase 1B protein (NT5C1B), or a NT5C1B isoform thereof, or a peptide fragment thereof, an isolated peptide thereof or a fusion protein comprising an isolated peptide of NT5C1A or NT5C1B. Such autoantibodies are only found in IBM patients and not in patients with other myopathies. | 12-18-2014 |